Patient | Authors | Year | Age (years)/sex | Aneurysm status/diameter | Celiac axis status | Treatment | Bypass | Graft | TAE | Interval between two treatments | Follow-up (months) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Bageacu et al. [4] | 2006 | 55/unknown | Ruptured (15 mm) | Stenosis | TAE → bypass/two-staged | Aorto-to-hepatic artery | Unknown | Coil embolization | 6 or 8 weeks | 89 |
2 | 43/unknown | Ruptured (20 mm) | Stenosis | TAE → bypass/two-staged | Aorto-to-hepatic artery | Unknown | Coil embolization | 6 or 8 weeks | 78 | ||
3 | 51/unknown | Unruptured (18 mm) | Occlusion | Bypass → TAE/two-staged | Aorto-to-hepatic artery | Unknown | Coil embolization | Unknown | 27 | ||
4 | Teng et al. [9] | 2006 | 46/M | Ruptured (19 mm) | Occlusion | Bypass → TAE/two-staged | Aorto-to-hepatic artery and SMA | Dacron | Coil embolization | 1 day | unknown |
5 | Imamura et al. [10] | 2011 | 61/M | Unruptured (20 mm) | Stenosis | Bypass → TAE/one-staged | Aorto-to-hepatic artery | SVG | Coil embolization | The same day | unknown |
6 | Nakano et al. [11] | 2014 | 47/M | Unruptured (35, 15 mm) | Occlusion | Bypass → TAE/two-staged | Renal-to-splenic artery | ePTFE | Coil embolization | 7 days | 21 |
7 | Simon et al. [12] | 2017 | 39/F | Unruptured (40 mm) | Occlusion | TAE → bypass/one-staged | Aorto-to-hepatic artery | SVG | Coil embolization | The same day | 12 |
8 | 61/F | Unruptured (20 mm) | Occlusion | Bypass → TAE/two-staged | Aorto-to-celiac artery | Dacron | Coil embolization | 1 month | 18 | ||
9 | Current report | 2021 | 54/F | Unruptured (21, 19 mm) | Occlusion | Bypass → TAE/two-staged | Aorto-to-splenic artery | Dacron | Coil embolization | 6 days | 102 |
10 | 39/M | Unruptured (23 mm) | Stenosis | Bypass → TAE/two-staged | Aorto-to-splenic artery | Dacron | Coil embolization | 9 days | 79 |